Patent details
EP3527224 Title: RSV IMMUNIZATION REGIMEN
Basic Information
- Publication number:
- EP3527224
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP191653021
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- RSV IMMUNIZATION REGIMEN
- French Title of Invention:
- RÉGIME D'IMMUNISATION CONTRE LE VRS
- German Title of Invention:
- RSV-IMMUNISIERUNGSTHERAPIE
- SPC Number:
Dates
- Filing date:
- 26/01/2012
- Grant date:
- 26/02/2025
- EP Publication Date:
- 21/08/2019
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 26/02/2025
- EP B1 Publication Date:
- 26/02/2025
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 26/01/2032
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 19/02/2025
- Name:
- GlaxoSmithKline Biologicals S.A.
- Address:
- Rue de l'Institut, 89, 1330 Rixensart, Belgium (BE)
Inventor
- Name:
- DORMITZER, Philip, R.
- Address:
- United States (US)
Priority
- Priority Number:
- 201161436355 P
- Priority Date:
- 26/01/2011
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 39/12; A61P 31/14;
Publication
European Patent Bulletin
- Issue number:
- 202509
- Publication date:
- 26/02/2025
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- 02/02/2026
- Annual Fee Number:
- 15
- Annual Fee Amount:
- 213 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|